NCT03849495View on ClinicalTrials.gov

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults

PHASE1UnknownINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 19, 2019

Primary Completion Date

March 17, 2019

Study Completion Date

March 21, 2019

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

CKD-370

Test drug

DRUG

D745

Reference drug

Trial Locations (1)

Unknown

RECRUITING

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT03849495 - Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults | Biotech Hunter | Biotech Hunter